ICD-10-CM Billable Code

M86.59

Other chronic hematogenous osteomyelitis, multiple sites

Clinical Classification Guidelines

Medical Intelligence & Overview

Chronic hematogenous osteomyelitis refers to a long-lasting bone infection that originates from bacteria traveling through the bloodstream. When this infection affects multiple sites, it can become a complex condition requiring careful medical attention. This form of osteomyelitis is characterized by persistent inflammation, bone destruction, and an ongoing immune response, often impacting patients' overall health. Proper understanding of this condition helps in recognizing symptoms and considering treatment options, although a healthcare professional's assessment is essential for diagnosis and management.

Causes & Symptoms

Clinical Causes: Bacterial infections, typically caused by Staphylococcus aureus, spreading through the bloodstream to various bones. Immunocompromised states such as diabetes, HIV, or chemotherapy that increase susceptibility to infections. Open fractures or bone injuries that introduce bacteria directly to bone tissue. Chronic infections in other parts of the body that can seed bacteria into the bloodstream. Repeated infections or inadequate initial treatment may lead to persistent osteomyelitis.

Key Symptoms: Persistent or recurrent bone pain localized to affected areas. Swelling, warmth, or redness over the affected bones or joints. Low-grade fever and night sweats in some cases. Fatigue and general malaise. Possible signs of infection spread, such as chills or increased discomfort. Limited mobility or function in the affected limbs or joints.

Diagnostic & Treatment

Diagnosis Path: Diagnosing multiple-site chronic hematogenous osteomyelitis involves a combination of clinical evaluation and diagnostic tests. Healthcare providers may consider the following tools:

Treatment Protocols: Management of this condition typically involves a comprehensive approach involving antimicrobial therapy and sometimes surgical intervention. The main treatment strategies include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M86.59 a billable ICD-10 code?
Yes, M86.59 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M86.59?
Clinical documentation must specify the nature of Other chronic hematogenous osteomyelitis, multiple sites and any associated comorbidities for accurate reporting.

Cite this Clinical Reference